Clinicians' prescribing practices for bariatric surgery patients: is there an issue?
- 10 October 2014
- journal article
- Published by Hindawi Limited in Journal of Clinical Pharmacy & Therapeutics
- Vol. 40 (1), 104-109
- https://doi.org/10.1111/jcpt.12217
Abstract
Patients undergoing Roux-en-Y gastric bariatric (RYGB) surgery present a reduced absorption site, and special attention should therefore be taken when prescribing oral-dosage forms. This study was carried out to investigate the extent to which non-bariatric clinicians are aware of this issue when prescribing medicines for this population, and what type of information is available to aid them in their decision-making.Two questionnaires were created, one for non-bariatric clinicians and another for their patients who had undergone RYGB surgery, to gather information about the prescription practices for this population. Additionally, a literature search of pharmacokinetic studies on bariatric patients and recommended prescription practices was carried out.Of the 62 non-bariatric clinicians surveyed, 50% believed RYGB surgery interferes with drug absorption; however, 68% still prescribed tablets as the first choice form of dosage. Young clinicians (35%) were less likely to believe that RYGB surgery could affect drug absorption than experienced clinicians (43%). The main reasons for changing dosage forms were patient complaints about efficacy or difficulty in swallowing tablets. Of the 73 patients, 43 were taking drugs in tablet form after the surgery, 24 of whom had health issues unrelated to the surgery. None of the journals read by the clinicians contained pharmacokinetics (PK) studies involving bariatric surgery patients or presented recommendations for the prescription of oral-dosage forms for this population. The literature search revealed a total of 22 drugs that had undergone PK studies in RYGB patients. Fifteen of them were reported to have decreased effects, 12 of which were administered as tablets.There is still a relative lack of clinical evidence to guide clinicians when prescribing medicines for bariatric patients. It is therefore recommended that pharmacists should have greater participation in the prescription process to advise non-bariatric clinicians and educate RYGB surgery patients to help avoid therapeutic failure.Keywords
Funding Information
- Brazilian Council for Scientific and Technological Development
This publication has 32 references indexed in Scilit:
- Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: Cosponsored by american association of clinical endocrinologists, The obesity society, and american society for metabolic & bariatric surgery*Obesity, 2013
- Metabolic/Bariatric Surgery Worldwide 2011Obesity Surgery, 2013
- Review article: the impact of bariatric surgery on gastrointestinal motilityAlimentary Pharmacology & Therapeutics, 2011
- Physiological Parameters for Oral Delivery and in Vitro TestingMolecular Pharmaceutics, 2010
- Reduced Phenytoin Levels in an Epileptic Patient following Roux-En-Y Gastric Bypass for ObesityObesity Surgery, 2010
- A systematic review of drug absorption following bariatric surgery and its theoretical implicationsObesity Reviews, 2009
- Malabsorption of Oral Antibiotics in Pregnancy after Gastric Bypass SurgeryThe Journal of the American Board of Family Medicine, 2007
- Medication and nutrient administration considerations after bariatric surgeryAmerican Journal of Health-System Pharmacy, 2006
- Prospective evaluation of gastric acid secretion and cobalamin absorption following gastric bypass for clinically severe obesityDigestive Diseases and Sciences, 1994
- Gastric Acid Secretion and Vitamin B12 Absorption After Vertical Rouxen-Y Gastric Bypass for Morbid ObesityAnnals of Surgery, 1993